Akebia Therapeutics
AKBA
$1.34
Share price
0.75%
Change (1 day)
47.25%
Change (1 year)
Categories
Akebia Therapeutics (AKBA) Fails to deliver data
Key failure to deliver metrics for Akebia Therapeutics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.31 M
- Last 3 months FTD volume: $0.41 M
- Last year FTD volume: $2.66 M
Failures to deliver for Akebia Therapeutics (AKBA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Akebia Therapeutics (AKBA) - since 2014
Volume in USD (price x number of shares), data since 2014Akebia Therapeutics (AKBA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.41 M | -84.62% |
| 2023 | $2.68 M | -41.28% |
| 2022 | $4.56 M | 8.92% |
| 2021 | $4.19 M | -18.58% |
| 2020 | $5.15 M | 43.43% |
| 2019 | $3.59 M | -62.25% |
| 2018 | $9.51 M | 238.71% |
| 2017 | $2.8 M | -25.14% |
| 2016 | $3.75 M | 92.2% |
| 2015 | $1.95 M | -88.22% |
| 2014 | $16.56 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.01 M | $7.04 M | 🇺🇸 USA |